Whole-brain radiotherapy was beneficial as consolidation, while temozolomide and etoposide were associated with decreased survival.

The integration of Bruton tyrosine kinase (BTK) inhibitors into first-line treatment regimens, in combination with ...

Molecular analysis identified ABC and GCB subtypes, with the ABC subtype benefiting more from the new regimen. The ...

VANCOUVER, British Columbia — In patients with refractory or relapsed aggressive lymphoma, immunoradiation combined with high-dose chemotherapy is associated with better progression-free and overall ...

Kyowa Kirin, the European subsidiary of the Japan-based specialty pharmaceutical company, and University Hospitals Birmingham ...

GALASHIELS & MARLOW, & BIRMINGHAM, United Kingdom, October 22, 2025--Kyowa Kirin International (KKI), a wholly owned subsidiary of Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), a Japan-based global ...

Consolidative radiotherapy (RT) can improve outcomes in patients with diffuse large B-cell lymphoma (DLBCL), according to a ...

Outcomes in patients (pts) with relapsed/refractory (R/R) diffuse large B cell lymphoma (DLBCL) treated with systemic therapy from real world experience (ORCHID) study. This is an ASCO Meeting ...

An immunotherapy approach to treating advanced Hodgkin lymphoma may drastically increase patients’ chances of survival, including those as young as 12, according to a new clinical trial. The regimen, ...

NSHL is the most common type of Hodgkin’s lymphoma and mostly affects children and young adults. It’s highly curable with prompt treatment, so recognizing the symptoms can be important. Hodgkin’s ...